Siga Technologies (SIGA) Non-Current Debt (2012 - 2019)
Siga Technologies (SIGA) posted Non-Current Debt of $78.9 million for Q3 2019, up 1.46% on a QoQ basis from $77.8 million in Q2 2019, and up 6.04% year-over-year from $74.4 million in Q3 2018.
Siga Technologies (SIGA) Non-Current Debt (2012 - 2019) Analysis & Trends
Siga Technologies' Non-Current Debt history runs 7 years deep, the most recent figure standing at $78.9 million for Q3 2019.
- Quarterly Non-Current Debt rose 6.04% year-over-year to $78.9 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $78.9 million (up 6.04% YoY) and the FY2018 annual result came in at $75.5 million, up 6.33% from the prior year.
- Non-Current Debt was $78.9 million for Q3 2019 at Siga Technologies, up from $77.8 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $78.9 million in Q3 2019 and bottomed at $66.6 million in Q4 2016.
- A 4-year average of $72.7 million and a median of $72.7 million in 2018 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2017 — Non-Current Debt gained 6.76% — and 2019, when it increased 6.04%.
- Siga Technologies' Non-Current Debt stood at $66.6 million in 2016, then advanced by 6.76% to $71.1 million in 2017, then gained by 6.33% to $75.5 million in 2018, then gained by 4.45% to $78.9 million in 2019.
- Business Quant data shows SIGA's Non-Current Debt at $78.9 million in Q3 2019, $77.8 million in Q2 2019, and $76.7 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 78.91 Mn |
| Jun 30, 2019 | 77.78 Mn |
| Mar 31, 2019 | 76.66 Mn |
| Dec 31, 2018 | 75.55 Mn |
| Sep 30, 2018 | 74.41 Mn |
| Jun 30, 2018 | 73.28 Mn |
| Mar 31, 2018 | 72.16 Mn |
| Dec 31, 2017 | 71.05 Mn |
| Sep 30, 2017 | 69.92 Mn |
| Jun 30, 2017 | 68.78 Mn |
| Mar 31, 2017 | 67.66 Mn |
| Dec 31, 2016 | 66.55 Mn |
| Sep 30, 2014 | 2.50 Mn |
| Jun 30, 2014 | 997,693.00 |
| Mar 31, 2014 | 1.49 Mn |
| Dec 31, 2013 | 1.99 Mn |
| Sep 30, 2013 | 2.48 Mn |
| Jun 30, 2013 | 2.98 Mn |
| Mar 31, 2013 | 3.47 Mn |
| Dec 31, 2012 | 3.96 Mn |